Drug regulator through executive order issued last August paved way for direct launch of certain categories of drugs approved in select countries by means of local clinical trials waiver.
Following December notice prohibiting combination of chlorpheniramine maleate & phenylephrine hydrochloride, CDSCO has ‘decided to rope in paediatricians to review other permitted FDCs’.
India's apex drug regulator will form a panel to examine whether more regulatory restrictions should be put in place. Experts say more curbs a good idea but implementation is key.
Former Bangladesh Prime Minister Sheikh Hasina has, in a sense, tasted her own medicine. The International Crimes Tribunal, the special court she instituted for...
While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.
Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.
COMMENTS